Trial Profile
An Open Label, Non-comparative Phase II Trial to Evaluate the Effects of Atorvastatin on the Persistent Coronary Arterial Aneurysm in Children With Kawasaki Disease: Safety and Efficacy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Aneurysm; Coronary disorders
- Focus Therapeutic Use
- 26 Jun 2014 New trial record